Lianbao Kong
- Hepatology top 5%
- Liver Disease and Transplantation 10
- Liver physiology and pathology 3
- Cancer Research top 10%
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 6
-
- Immune cells in cancer 4
-
- Circular RNAs in diseases 10
- RNA modifications and cancer 4
-
- Organ Transplantation Techniques and Outcomes 13
- Co-authors
- Liyong PuXuehao WangDeming ZhuWeiwei JiangBeicheng SunXiangcheng LiQingfeng NiLiangliang Kong
- Cited by
- HepatologyCancer ResearchImmunology
- Journals
- The Journal of Immunology (1 paper)PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited KingdomTaiwan
In The Last Decade
Lianbao Kong
44 papers receiving 752 citations
Peers
Comparison fields: 5 of 80
- Hepatology 154
- Cancer Research 247
- Immunology 153
- Molecular Biology 334
- Surgery 195
Countries citing papers authored by Lianbao Kong
This map shows the geographic impact of Lianbao Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianbao Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianbao Kong more than expected).
Fields of papers citing papers by Lianbao Kong
This network shows the impact of papers produced by Lianbao Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianbao Kong. The network helps show where Lianbao Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lianbao Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 28 | |
| 13 | 2014 | 14 | |
| 14 | 2014 | 20 | |
| 15 | 2013 | 35 | |
| 16 | 2010 | 3 | |
| 17 | 2009 | 3 | |
| 18 | 2009 | 52 | |
| 19 | 2007 | 24 | |
| 20 | 2006 | 22 |
About Lianbao Kong
Lianbao Kong is a scholar working on Hepatology, Cancer Research and Immunology, having authored 46 papers that have together received 760 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Organ Transplantation Techniques and Outcomes (13 papers), Liver Disease and Transplantation (10 papers), Circular RNAs in diseases (10 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Immune cells in cancer (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (154 citations), Cancer Research (247 citations) and Immunology (153 citations). Lianbao Kong has collaborated with scholars based in China, United Kingdom and Taiwan. Frequent co-authors include Liyong Pu, Xuehao Wang, Deming Zhu, Weiwei Jiang, Beicheng Sun, Xiangcheng Li, Qingfeng Ni, Liangliang Kong, Weibing Tang and Zhi Li. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.